Nano Cap New Millennium Growth Fund L P Invests $1.77 Million in Simulations Plus, Inc. $SLP

Nano Cap New Millennium Growth Fund L P acquired a new stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 97,000 shares of the technology company’s stock, valued at approximately $1,768,000. Simulations Plus accounts for about 1.5% of Nano Cap New Millennium Growth Fund L P’s holdings, making the stock its 14th largest position.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Tudor Investment Corp ET AL bought a new stake in Simulations Plus in the 3rd quarter worth approximately $1,810,000. Royce & Associates LP lifted its holdings in shares of Simulations Plus by 31.6% during the 3rd quarter. Royce & Associates LP now owns 348,758 shares of the technology company’s stock valued at $5,256,000 after buying an additional 83,758 shares during the period. Nicholas Company Inc. boosted its stake in shares of Simulations Plus by 42.9% in the 4th quarter. Nicholas Company Inc. now owns 262,712 shares of the technology company’s stock worth $4,789,000 after buying an additional 78,854 shares during the last quarter. Herald Investment Management Ltd purchased a new position in shares of Simulations Plus in the 3rd quarter worth $3,016,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of Simulations Plus by 154.7% in the third quarter. JPMorgan Chase & Co. now owns 167,646 shares of the technology company’s stock worth $2,526,000 after acquiring an additional 101,822 shares during the period. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Stock Performance

SLP opened at $15.11 on Friday. Simulations Plus, Inc. has a fifty-two week low of $11.09 and a fifty-two week high of $34.01. The firm’s fifty day moving average is $13.40 and its 200 day moving average is $15.66. The stock has a market cap of $305.22 million, a price-to-earnings ratio of -4.83 and a beta of 1.28.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Thursday, April 9th. The technology company reported $0.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.08. The business had revenue of $24.29 million during the quarter, compared to analyst estimates of $21.66 million. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%. On average, equities research analysts predict that Simulations Plus, Inc. will post 0.85 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently commented on the company. TD Cowen reduced their price objective on Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 10th. Wall Street Zen upgraded Simulations Plus from a “hold” rating to a “buy” rating in a research note on Saturday, May 16th. Finally, Zacks Research cut shares of Simulations Plus from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 2nd. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $24.40.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.